- Home
- QNCX vs FSEA Comparison
QNCX vs FSEA Comparison
Compare QNCX & FSEA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QNCX
- FSEA
- Stock Information
- Founded
- QNCX 2012
- FSEA 1890
- Country
- QNCX United States
- FSEA United States
- Employees
- QNCX N/A
- FSEA N/A
- Industry
- QNCX Biotechnology: Biological Products (No Diagnostic Substances)
- FSEA Savings Institutions
- Sector
- QNCX Health Care
- FSEA Finance
- Exchange
- QNCX Nasdaq
- FSEA Nasdaq
- Market Cap
- QNCX 47.7M
- FSEA 53.3M
- IPO Year
- QNCX 2019
- FSEA N/A
- Fundamental
- Price
- QNCX $1.31
- FSEA $11.31
- Analyst Decision
- QNCX Strong Buy
- FSEA
- Analyst Count
- QNCX 5
- FSEA 0
- Target Price
- QNCX $8.00
- FSEA N/A
- AVG Volume (30 Days)
- QNCX 302.6K
- FSEA 5.9K
- Earning Date
- QNCX 08-12-2025
- FSEA 08-08-2025
- Dividend Yield
- QNCX N/A
- FSEA N/A
- EPS Growth
- QNCX N/A
- FSEA N/A
- EPS
- QNCX N/A
- FSEA 0.00
- Revenue
- QNCX N/A
- FSEA $16,196,000.00
- Revenue This Year
- QNCX N/A
- FSEA N/A
- Revenue Next Year
- QNCX N/A
- FSEA N/A
- P/E Ratio
- QNCX N/A
- FSEA $1,365.55
- Revenue Growth
- QNCX N/A
- FSEA 97.61
- 52 Week Low
- QNCX $0.51
- FSEA $8.60
- 52 Week High
- QNCX $2.45
- FSEA $11.80
- Technical
- Relative Strength Index (RSI)
- QNCX 64.64
- FSEA 51.70
- Support Level
- QNCX $1.29
- FSEA $11.00
- Resistance Level
- QNCX $1.45
- FSEA $11.33
- Average True Range (ATR)
- QNCX 0.09
- FSEA 0.17
- MACD
- QNCX 0.03
- FSEA -0.01
- Stochastic Oscillator
- QNCX 76.74
- FSEA 60.00
About QNCX Quince Therapeutics Inc.
Quince Therapeutics Inc is preclinical stage biopharmaceutical company focused on advancing precision therapeutics for debilitating and rare diseases. The company discovered a broad bone-targeting drug platform designed to precisely deliver small molecules, peptides, or large molecules directly to the site of bone fracture and disease to promote rapid healing with fewer off-target safety concerns compared to non-targeted therapeutics. Company pipeline includes Ataxia-Telangiectasia(EryDex), Duchenne Muscular Dystrophy, New Indications and Program Expansion Potential.
About FSEA First Seacoast Bancorp Inc.
First Seacoast Bancorp Inc is a savings and loan holding company. Its business consists of taking deposits from the general public and investing those deposits, together with funds generated from operations and borrowings from the Federal Home Loan Bank, in one-to-four-family residential real estate loans, commercial real estate, and multi-family real estate loans, acquisition, development and land loans, commercial and industrial loans, home equity loans and lines of credit and consumer loans. The company generates revenue from financial instruments, such as loans, letters of credit, and investment securities, as well as revenue related to mortgage servicing activities, and bank-owned life insurance.